Form 8-K Fortress Biotech, Inc. For: Aug 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Fortress Biotech (FBIO) PT Raised to $13 at Roth/MKM
August 14, 2024 5:06 AM EDTRoth/MKM analyst Jason Whittes raised the price target on Fortress Biotech (NASDAQ: FBIO) to $13.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "FBIO reported 2Q24 revenues down 14.4% to $14.9 million vs. consensus of $14.8 million and our estimate of $14.0 million. EPS was ($0.73) vs.... More
